{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:09:30Z","timestamp":1773702570239,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"USDA, Agricultural Research Service","award":["appropriated funds"],"award-info":[{"award-number":["appropriated funds"]}]},{"DOI":"10.13039\/100000180","name":"Department of Homeland Security","doi-asserted-by":"publisher","award":["HSHQDC 16-A-B0006"],"award-info":[{"award-number":["HSHQDC 16-A-B0006"]}],"id":[{"id":"10.13039\/100000180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic pathogen that causes periodic outbreaks of abortion in ruminant species and hemorrhagic disease in humans in sub-Saharan Africa. These outbreaks have a significant impact on veterinary and public health. Its introduction to the Arabian Peninsula in 2003 raised concerns of further spread of this transboundary pathogen to non-endemic areas. These concerns are supported by the presence of competent vectors in many non-endemic countries. There is no licensed RVF vaccine available for humans and only a conditionally licensed veterinary vaccine available in the United States. Currently employed modified live attenuated virus vaccines in endemic countries lack the ability for differentiating infected from vaccinated animals (DIVA). Previously, the efficacy of a recombinant subunit vaccine based on the RVFV Gn and Gc glycoproteins, derived from the 1977 human RVFV isolate ZH548, was demonstrated in sheep. In the current study, cattle were vaccinated subcutaneously with the Gn only, or Gn and Gc combined, with either one or two doses of the vaccine and then subjected to heterologous virus challenge with the virulent Kenya-128B-15 RVFV strain, isolated from Aedes mosquitoes in 2006. The elicited immune responses by some vaccine formulations (one or two vaccinations) conferred complete protection from RVF within 35 days after the first vaccination. Vaccines given 35 days prior to RVFV challenge prevented viremia, fever and RVFV-associated histopathological lesions. This study indicates that a recombinant RVFV glycoprotein-based subunit vaccine platform is able to prevent and control RVFV infections in target animals.<\/jats:p>","DOI":"10.3390\/vaccines9070748","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T23:53:51Z","timestamp":1625615631000},"page":"748","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preliminary Evaluation of a Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Providing Full Protection against Heterologous Virulent Challenge in Cattle"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-9224","authenticated-orcid":false,"given":"William C.","family":"Wilson","sequence":"first","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Arthropod Borne Animal Disease Research Unit, Manhattan, KS 66502, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonto","family":"Faburay","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-022X","authenticated-orcid":false,"given":"Jessie D.","family":"Trujillo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-6015","authenticated-orcid":false,"given":"Izabela","family":"Ragan","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4688-641X","authenticated-orcid":false,"given":"Sun-Young","family":"Sunwoo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Morozov","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4625-954X","authenticated-orcid":false,"given":"Vinay","family":"Shivanna","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Balogh","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-9216","authenticated-orcid":false,"given":"Kinga","family":"Urbaniak","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8321-3287","authenticated-orcid":false,"given":"D. Scott","family":"McVey","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Arthropod Borne Animal Disease Research Unit, Manhattan, KS 66502, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dashzeveg","family":"Bold","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha N.","family":"Gaudreault","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Schirtzinger","sequence":"additional","affiliation":[{"name":"United States Department of Agriculture, Agricultural Research Service, Arthropod Borne Animal Disease Research Unit, Manhattan, KS 66502, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7308-5672","authenticated-orcid":false,"given":"Juergen A.","family":"Richt","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Medicine\/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/emi.2015.33","article-title":"Major emerging vector-borne zoonotic diseases of public health importance in Canada","volume":"4","author":"Kulkarni","year":"2015","journal-title":"Emerg. Microb. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kading, R.C., Golnar, A.J., Hamer, S.A., and Hamer, G.L. (2018). Advanced surveillance and preparedness to meet a new era of invasive vectors and emerging vector-borne diseases. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006761"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/1469-0691.12163","article-title":"Relevance of Rift Valley fever to public health in the European Union","volume":"19","author":"Chevalier","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jmedent\/47.5.884","article-title":"Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus","volume":"47","author":"Turell","year":"2010","journal-title":"J. Med. Entomol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","article-title":"Rift Valley Fever: A Mosquito-Borne Emerging Disease","volume":"61","author":"Linthicum","year":"2016","journal-title":"Annu. Rev. Entomol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: A 12-year experience","volume":"18","author":"Pittman","year":"1999","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.vaccine.2015.12.030","article-title":"Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.vaccine.2015.11.078","article-title":"Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates","volume":"34","author":"Pittman","year":"2016","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Faburay, B., LaBeaud, A., McVey, D., Wilson, W., and Richt, J.A. (2017). Current Status of Rift Valley Fever Vaccine Development. Vaccines, 5.","DOI":"10.3390\/vaccines5030029"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"Engelbrecht","year":"2011","journal-title":"Vaccine"},{"key":"ref_12","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Makoschey, B., van Kilsdonk, E., Hubers, W.R., Vrijenhoek, M.P., Smit, M., Wichgers Schreur, P.J., Kortekaas, J., and Moulin, V. (2016). Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004550"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus","volume":"95","author":"Ikegami","year":"2012","journal-title":"Antivir. Res"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong rift valley Fever virus neutralizing antibody response in sheep","volume":"14","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-2516(07)80002-1","article-title":"The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity","volume":"145","author":"Besselaar","year":"1994","journal-title":"Res. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01309641","article-title":"The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins","volume":"125","author":"Besselaar","year":"1992","journal-title":"Arch. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0923-2516(91)90069-F","article-title":"Antigenic analysis of Rift Valley fever virus isolates: Monoclonal antibodies distinguish between wild-type and neurotropic virus strains","volume":"142","author":"Besselaar","year":"1991","journal-title":"Res. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/CVI.05420-11","article-title":"The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus","volume":"19","author":"Fernandez","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.vaccine.2005.08.034","article-title":"Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus","volume":"24","author":"Spik","year":"2006","journal-title":"Vaccine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27719","DOI":"10.1038\/srep27719","article-title":"A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep","volume":"6","author":"Faburay","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3201\/eid0812.020194","article-title":"Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia","volume":"8","author":"Miller","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2012.1285","article-title":"Rift Valley fever virus structural and nonstructural proteins: Recombinant protein expression and immunoreactivity against antisera from sheep","volume":"13","author":"Faburay","year":"2013","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jviromet.2013.07.006","article-title":"Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments","volume":"193","author":"Wilson","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2007.07.031","article-title":"Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo","volume":"127","author":"Paweska","year":"2008","journal-title":"Vet. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01626-17","DOI":"10.1128\/JCM.01626-17","article-title":"Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins","volume":"56","author":"Ragan","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wilson, W.C., Davis, A.S., Gaudreault, N.N., Faburay, B., Trujillo, J.D., Shivanna, V., Sunwoo, S.-Y., Balogh, A., Endalew, A., and Ma, W. (2016). Experimental infection of calves by two genetically-distinct strains of Rift Valley fever virus. Viruses, 8.","DOI":"10.3390\/v8050145"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: A clinical study of severe illness in humans","volume":"36","author":"Ayoola","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Maluleke, M.R., Phosiwa, M., van Schalkwyk, A., Michuki, G., Lubisi, B.A., Kegakilwe, P.S., Kemp, S.J., and Majiwa, P.A.O. (2019). A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008\u20132010. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0006576"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3201\/eid2502.181289","article-title":"Rift Valley Fever Reemergence after 7 Years of Quiescence, South Africa, May 2018","volume":"25","author":"Kgaladi","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/vms3.135","article-title":"First occurrence of Rift Valley fever outbreak in Niger, 2016","volume":"5","author":"Lagare","year":"2019","journal-title":"Vet. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.18-0732","article-title":"First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years","volume":"100","author":"Shoemaker","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_34","unstructured":"WHO (2019, December 08). Rift Valley Fever\u2014Mayotte (France). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rift-valley-fever."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40588-018-0110-1","article-title":"Rift Valley Fever Virus\u2014How and Where Virus Is Maintained during Inter-epidemic Periods","volume":"6","author":"Njenga","year":"2018","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/2193-1801-2-549","article-title":"Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania","volume":"2","author":"Chengula","year":"2013","journal-title":"SpringerPlus"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/vbz.2014.1721","article-title":"Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine","volume":"16","author":"Hossain","year":"2016","journal-title":"Vector Borne Zoonotic Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"20617","DOI":"10.1038\/srep20617","article-title":"Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever","volume":"6","author":"Warimwe","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wichgers Schreur, P.J., Tacken, M., Gutjahr, B., Keller, M., van Keulen, L., Kant, J., van de Water, S., Lin, Y., Eiden, M., and Rissmann, M. (2021). Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus. Vaccines, 9.","DOI":"10.3390\/vaccines9030301"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/7\/748\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:51Z","timestamp":1760164011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/7\/748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["vaccines9070748"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9070748","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}